News | November 12, 2025
JB Pharma Q2 PAT up 19 % at Rs. 208 Cr
Net profit for the half-year rose to Rs. 410 crore from Rs. 351 crore
Net profit for the half-year rose to Rs. 410 crore from Rs. 351 crore
He has previously served in pivotal HR leadership roles at RPG Life Sciences, Akumentis Healthcare, and Wockhardt
Shelcal Total marks the brand’s evolution into a modern, consumer-focused nutrition portfolio
Acquisition to be followed by merger; strengthens Torrent’s IPM market presence
The revenue witnessed a growth of 7.80 per cent on a year-on-year basis at Rs. 2,959 crore
Pregabalin Gel 8% is a novel topical solution for diabetic neuropathic pain
The acquisition further strengthens Torrent’s existing diabetes care portfolio and its presence in the Oral Anti Diabetic market
e brings over 27+ years of rich pharmaceutical experience
Vonoprozan is a novel potassium-competitive acid blocker used for the treatment of acid related disorders
He will be responsible for leading all the activities related to the Research & Development (Formulations) Division of the company
Subscribe To Our Newsletter & Stay Updated
